Jane Street’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-35,081
Closed -$6.42K – 9762
2023
Q2
$6.42K Buy
35,081
+20,784
+145% +$19.9K ﹤0.01% 8478
2023
Q1
$22.9K Sell
14,297
-26,737
-65% -$54.4K ﹤0.01% 8615
2022
Q4
$81.7K Buy
41,034
+20,039
+95% +$49.4K ﹤0.01% 8203
2022
Q3
$73K Sell
20,995
-2,893
-12% -$11K ﹤0.01% 8785
2022
Q2
$81K Buy
+23,888
New +$132K ﹤0.01% 8756
2022
Q1
– Sell
-1,464
Closed -$31K – 11432
2021
Q4
$31K Sell
1,464
-4,327
-75% -$116K ﹤0.01% 9693
2021
Q3
$189K Buy
+5,791
New +$212K ﹤0.01% 8892
2020
Q4
– Sell
-739
Closed -$40K – 8392
2020
Q3
$40K Sell
739
-226
-23% -$17.3K ﹤0.01% 6955
2020
Q2
$92K Buy
965
+55
+6% +$4.1K ﹤0.01% 6734
2020
Q1
$47K Buy
+910
New +$95.1K ﹤0.01% 5098
2019
Q3
– Sell
-510
Closed -$65K – 6004
2019
Q2
$65K Buy
+510
New +$73.4K ﹤0.01% 4922
2018
Q1
– Sell
-382
Closed -$47K – 5634
2017
Q4
$47K Buy
+382
New +$52.5K ﹤0.01% 4428
2013
Q4
– Sell
-2,628
Closed -$295K – 3050
2013
Q3
$295K Sell
2,628
-1,695
-39% -$192K ﹤0.01% 2110
2013
Q2
$488K Buy
+4,323
New +$529K 0.01% 1478

Other funds holding SRGA

Jane Street's SRGA Position: Q3 2023 in Review

Jane Street sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2023, closing a stake of 35,081 shares — an estimated $6.42K sold.

Jane Street first reported a position in SRGA in Q2 2013 and held it in 14 quarters. The position peaked at $488K in Q2 2013. 4 funds tracked by Wall St. Rank hold SRGA as of Q3 2023.

  • Jane Street reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 35,081 Surgalign Holdings, Inc. Common Stock shares in Q3 2023, an estimated $6.42K.
  • Jane Street first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 14 quarters.
  • Jane Street's Surgalign Holdings, Inc. Common Stock position peaked at $488K in Q2 2013.
  • 4 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.